Search

Current filters:
Add Filter:

Results

Customise results display
Item hits:
Issue DateTitleAuthor(s)
2020-01Increased Efficacy of Histone Methyltransferase G9a Inhibitors Against <i>MYCN</i>-Amplified Neuroblastoma.Bellamy, J; Szemes, M; Melegh, Z; Dallosso, A; Kollareddy, M; Catchpoole, D; Malik, K
2018-04Wnt Signalling Drives Context-Dependent Differentiation or Proliferation in Neuroblastoma.Szemes, M; Greenhough, A; Melegh, Z; Malik, S; Yuksel, A; Catchpoole, D; Gallacher, K; Kollareddy, M; Park, JH; Malik, K
2021-02-06Transcriptomic Analyses of MYCN-Regulated Genes in Anaplastic Wilms' Tumour Cell Lines Reveals Oncogenic Pathways and Potential Therapeutic Vulnerabilities.Szemes, M; Melegh, Z; Bellamy, J; Park, JH; Chen, B; Greenhough, A; Catchpoole, D; Malik, K
2015-03Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells.Park, JH; Szemes, M; Vieira, GC; Melegh, Z; Malik, S; Heesom, KJ; Von Wallwitz-Freitas, L; Greenhough, A; Brown, KW; Zheng, YG; Catchpoole, D; Deery, MJ; Malik, K
2015-11-24LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma.Vieira, GC; Chockalingam, S; Melegh, Z; Greenhough, A; Malik, S; Szemes, M; Park, JH; Kaidi, A; Zhou, L; Catchpoole, D; Morgan, R; Bates, DO; Gabb, PD; Malik, K
2017-05-09Correction: LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma.Vieira, GC; Chockalingam, S; Melegh, Z; Greenhough, A; Malik, S; Szemes, M; Park, JH; Kaidi, A; Zhou, L; Catchpoole, D; Morgan, R; Bates, DO; Gabb, PJ; Malik, K
Results 1-6 of 6 (Search time: 0.235 seconds).
  • previous
  • 1
  • next